Acute Myeloid Leukemia Research Today is a free monthly online journal that collates and summarizes the latest research about Acute Myeloid Leukemia, including details on aml, symptoms, treatment, information.

Volume 3 (2006), Issue 2 (February)

1. Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients.
   J Natl Cancer Inst, 98(3): 215-8. [Abstract] [Full-text]
2. Stability of parental understanding of random assignment in childhood leukemia trials: an empirical examination of informed consent.
   J Clin Oncol, 24(6): 891-7. [Abstract] [Full-text]
3. Low p53 expression of acute myelocytic leukemia cells with t(8;21) chromosome abnormality: association with low p14(ARF) expression.
   Leuk Res, 30(4): 379-83. [Abstract] [Full-text]
4. Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia.
   Leuk Res, 30(4): 407-13. [Abstract] [Full-text]
5. Minimal residual core binding factor AMLs by real time quantitative PCR--initial response to chemotherapy predicts event free survival and close monitoring of peripheral blood unravels the kinetics of relapse.
   Leuk Res, 30(4): 389-95. [Abstract] [Full-text]
6. KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group.
   Blood, 107(5): 1806-9. [Abstract] [Full-text]
7. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment.
   Blood, 107(5): 1761-7. [Abstract] [Full-text]
8. 131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.
   Blood, 107(5): 2184-91. [Abstract] [Full-text]
9. KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival.
   Blood, 107(5): 1791-9. [Abstract] [Full-text]

© 2004-2008 Acute Myeloid Leukemia Research Today. All Rights Reserved.